Treatment of Hepatitis C With the Earliest Protease Inhibitor-Based Therapy

被引：0
|
作者：
Smith, Zohreh Movahedi [1 ]
Brussman, Keith [1 ]
Nadir, Abdul [1 ]
机构：
[1] Maricopa Cty Gen Hosp, Phoenix, AZ 85008 USA
来源：
MAYO CLINIC PROCEEDINGS | 2014年 / 89卷 / 09期
关键词：
TRIPLE THERAPY; GENOTYPE;
D O I：
10.1016/j.mayocp.2014.06.020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1319 / 1320
页数：3
相关论文
共 50 条
  • [41] Telaprevir: A novel, protease inhibitor for the treatment of hepatitis C virus
    Patel, Kejal
    Pauli, Maribeth
    Abdelghany, Sam
    FORMULARY, 2011, 46 (06) : 205 - +
  • [42] A Synthesis of a Spirocyclic Macrocyclic Protease Inhibitor for the Treatment of Hepatitis C
    Chung, Cheol K.
    Cleator, Ed
    Dumas, Aaron M.
    Hicks, Jacqueline D.
    Humphrey, Guy R.
    Maligres, Peter E.
    Nolting, Andrew F.
    Rivera, Nelo
    Ruck, Rebecca T.
    Shevlin, Michael
    ORGANIC LETTERS, 2016, 18 (06) : 1394 - 1397
  • [43] Partial treatment interruption of protease inhibitor-based highly active antiretroviral therapy regimens in HIV-infected children
    Abadi, J
    Sprecher, E
    Rosenberg, MG
    Dobroszycki, J
    Sansary, J
    Fennelly, G
    Wiznia, A
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (03) : 298 - 303
  • [44] Two Years' Persistence of Naturally Present Substitution R155K Within Hepatitis C Virus NS3 Protease in the Absence of Protease Inhibitor-based Therapy Reply
    Kim, Arthur Y.
    Timm, Joerg
    Bloom, Allyson K.
    Allen, Todd M.
    JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (09): : 1342 - 1343
  • [45] Postprandial response to a physiologic caloric load in HIV-positive patients receiving protease inhibitor-based or nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
    Thomas-Geevarghese, A
    Raghavan, S
    Minolfo, R
    Holleran, S
    Ramakrishnan, R
    Ormsby, B
    Karmally, W
    Ginsberg, HN
    El-Sadr, WM
    Albu, J
    Berglund, L
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2005, 82 (01): : 146 - 154
  • [46] Gut Bacterial Communities in HIV-Infected Individuals with Metabolic Syndrome: Effects of the Therapy with Integrase Strand Transfer Inhibitor-Based and Protease Inhibitor-Based Regimens
    Baltazar-Diaz, Tonatiuh Abimael
    Amador-Lara, Fernando
    Andrade-Villanueva, Jaime F.
    Gonzalez-Hernandez, Luz Alicia
    Cabrera-Silva, Rodolfo Ismael
    Sanchez-Reyes, Karina
    Alvarez-Zavala, Monserrat
    Valenzuela-Ramirez, Aldo
    Del Toro-Arreola, Susana
    Bueno-Topete, Miriam Ruth
    MICROORGANISMS, 2023, 11 (04)
  • [47] Proteasome inhibitor-based therapy for treatment of newly diagnosed multiple myeloma
    Vandross, Andrae
    SEMINARS IN ONCOLOGY, 2017, 44 (06) : 381 - 384
  • [48] Real-life experience of switching to protease inhibitor-based dual antiretroviral therapy (PIDAT)
    McNulty, M.
    Orkin, C.
    Smith, C.
    Marshall, N.
    Swaden, L.
    Burns, F.
    HIV MEDICINE, 2017, 18 : 17 - 18
  • [49] Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe
    Santos, J. R.
    Cozzi-Lepri, A.
    Phillips, A.
    De Wit, S.
    Pedersen, C.
    Reiss, P.
    Blaxhult, A.
    Lazzarin, A.
    Sluzhynska, M.
    Orkin, C.
    Duvivier, C.
    Bogner, J.
    Gargalianos-Kakolyris, P.
    Schmid, P.
    Hassoun, G.
    Khromova, I.
    Beniowski, M.
    Hadziosmanovic, V.
    Sedlacek, D.
    Paredes, R.
    Lundgren, J. D.
    HIV MEDICINE, 2018, 19 (05) : 324 - 338
  • [50] Altered viral fitness of HIV-1 following failure of protease inhibitor-based therapy
    Picchio, GR
    Valdez, H
    Sabbe, R
    Landay, AL
    Kuritzkes, DR
    Lederman, MM
    Mosier, DE
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (04) : 289 - 295
12345